Ixchiq Vaccine Linked to Fatal Adverse Events in Seniors, FDA and CDC Urge Caution

Source: Pharmacy Times articles

FDA and CDC halt Ixchiq chikungunya vaccine for adults 60 years and older due to severe adverse events, including fatalities, urging caution in vaccination practices.
Read More